Show Only:
  • Life Sciences Gets a COVID Booster Shot

    Three veterans of the life sciences private equity and M&A market share intel about dramatic changes in the industry.

    March 29, 2021
    More
  • Sun Capital is Bullish on Healthcare Done Right

    Two veterans of the Florida-based private equity firm describe their successful investments in, respectively, a primary care clinic and a dermatology business. Dan Florian and Stephen Cella of Sun Capital Partners also discuss the effects of COVID on the healthcare industry, the growth of telehealth, winning versus challenged business models as healthcare evolves, and patient empowerment. 

    March 22, 2021
    More
  • The Tax Function as Value-Add Lever

    A new RSM tax technology solution called PartnerSight.

    March 21, 2021
    More
  • New Mountain’s Steve Klinsky: Passionate About Education

    The founder of a major private equity firm discusses his project to lower the cost of college education.

    March 15, 2021
    More
  • Gaming: The Next Frontier for the Sports Business

    A veteran sports-business investment banker and the CEO of an NHL team discuss sports gambling being brought “out from the darkness” as a major business opportunity.

    March 15, 2021
    More
  • The Tax Function as Value-Add Lever

    Two veterans of the private equity tax function discuss the challenges of getting data tax-ready, the finance team’s move to high-value tax analysis, and a new RSM tax technology solution called PartnerSight. Click here to learn more about PartnerSight.

    March 3, 2021
    More
  • Grappling With the Supply Chain of the Future

    A conversation with KKR’s Neil Brown, who takes a deep dive into the effect that a massive disruption of the global supply chain is having on businesses. Brown, a Managing Director for the KKR Global Institute and KKR Infrastructure, discusses the impact of digital services, changing consumer priorities, the US-China relationship and the future of…

    March 3, 2021
    More
  • Life Sciences Gets a COVID Booster Shot

    Three veterans of the life sciences private equity and M&A market share intel about dramatic changes in the industry.

    March 1, 2021
    More